Overview: A plaintiff suing over Stryker’s recalled ABG II Modular hip implant has moved to have federal lawsuits consolidated into a federal multidistrict litigation in Minnesota. Some 30 lawsuits have been filed over metal-on-metal hip implants since they were recalled in July 2012. As with other all-metal hip replacements, the recall was based on a risk of corrosion leading to complications and early revision surgery. Australian regulators recently updated regulations for patients implanted with the device.
- A motion has been filed to consolidate Stryker Rejuvenate lawsuits into Minnesota federal court
- The Stryker ABG II Modular system was recalled in July 2012 due to a risk of corrosion
- At least 30 lawsuits filed in 12 federal districts over the recalled hip implant
Product: ABG II Modular Femoral Stem and Modular Neck system
Side Effects & Complications
- High failure rate
- Necrosis (tissue death)
- Increased levels of cobalt and chromium ions
- Pain at the implant, sometimes spreading to the groin and back
- Osteolysis (bone loss)
- Fluid collections/solid masses around the hip joint
Motion Filed to Consolidate Rejuvenate ABG II Lawsuits
According to a motion filed on February 19th with the U.S. Judicial Panel on Multidistrict Litigation (JPML), some 30 Stryker Rejuvenate ABG II Modular hip implant lawsuits have been filed in 12 districts since the devices were recalled. One Plaintiff has filed a motion to have federal lawsuits consolidated in Minnesota federal court for pretrial proceedings. Court records show that a consolidated litigation has already been created in Bergen County Superior court for New Jersey lawsuits. Judge Brian R. Martinotti is presiding over the litigation. The case is known as In Re: Stryker Rejuvenate Hip Stem and the ABG II Modular Hip Stem Litigation, No. 296.
Rejuvenate ABG II Recall
Stryker recalled the ABG II Modular system in July 2012. The company said that the recall was based on the risk of metal corrosion between the neck and stem, potentially leading to complications and causing the need for early revision surgery. This week, Australia’s Therapeutic Goods Administration (TGA) issued new guidelines for patients implanted with the device. Now, the agency advises that patients go through soft tissue imaging and metal ion testing even if they do not experience symptoms. The recall is not the only issue Stryker has had with metal-on-metal hip implants. Previously, the company recommended against using their Accolade femoral stems with Mitch TRH acetabular cups and Mitch TRH modular heads manufactured by DePuy’s Finsbury Orthopaedics unit.